<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190831044650N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-18</date_registration>
      <primary_sponsor>Qaemshahr branch, Islamic Azad University</primary_sponsor>
      <public_title>Effect of 8 weeks of Pilates exercise and vitamin D  on Tumor necrosis factor-α  and interleukin-10 levels in overweight men</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the changes of Tumor necrosis factor-α and  Interleukin-10 after 8 weeks of regular Pilates exercise and vitamin D intake in overweight men</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-12-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>56</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45986</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: The subjects will be divided into four groups of control, exercise, vitamin D and exercise + vitamin D using simple randomization table. First a number is assigned to each person. Then, using the random number table of each selected number, it is assigned to one of the groups at random and will continue until the number of individuals in each group is completed. Therefore, the researcher will have no option to change or predict the status of individuals. Random concealment will be done by a third person who does not participate in other stages of intervention, Blinding description: Participants and analysts will be blind. The researcher will administer vitamin D capsules (50,000 units) to vitamin D and exercise + vitamin D  individuals as well as placebo to control and exercise groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Obesity and overweight.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Exercise group will perform 8 weeks of Pilates exercises with 50-55% of heart rate reserve, one set and 10 repetitions in the first week and 65-70% reserve heart rate, 4 sets with 12 repetitions in eighth week (with increase A gradual 5% vigorous exercise, one set and 2 reps every two weeks). They will also take a placebo capsule containing oral paraffin weekly in a single blind manner. Intervention 2: Intervention group II: Vitamin D group, who take 50,000 IU of vitamin D capsules once a week for 8 weeks in a single blind manner. Intervention 3: Intervention group 3: Subjects in this group will have 8 weeks of Pilates  exercises similar to the exercise group and will consume 50,000 IU of vitamin D capsules once a week in a single blind manner. Intervention 4: Control group: There is no intervention in the control group and they are given placebo in a single blind manner.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>masoumeh habibian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7km Allameh Tabarasi street, Qaemshahr Branch, Islamic Azad University, Qaemshahr</address>
        <city>Qaemshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4765161964</zip>
        <telephone>+98 11 4224 1041</telephone>
        <email>habibian_m@yahoo.com</email>
        <affiliation>Qaemshahr branch, Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>masoumeh habibian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7km Allameh Tabarasi street, Qaemshahr Branch, Islamic Azad University, Qaemshahrر</address>
        <city>Qaemshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4765161964</zip>
        <telephone>+98 11 4224 1041</telephone>
        <email>habibian_m@yahoo.com</email>
        <affiliation>Qaemshahr branch, Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being overweight
Not having regular exercise for the past six months
Ability to perform exercise training
Not having cardiovascular disease
Not having hypertension</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>55 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Use of specific drugs
Use of supplement
smoking</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obesity due to excess calories</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Exercise group will perform 8 weeks of Pilates exercises with 50-55% of heart rate reserve, one set and 10 repetitions in the first week and 65-70% reserve heart rate, 4 sets with 12 repetitions in eighth week (with increase A gradual 5% vigorous exercise, one set and 2 reps every two weeks). They will also take a placebo capsule containing oral paraffin weekly in a single blind manner</i_keyword>
      <i_keyword>Intervention group II: Vitamin D group, who take 50,000 IU of vitamin D capsules once a week for 8 weeks in a single blind manner</i_keyword>
      <i_keyword>Intervention group 3: Subjects in this group will have 8 weeks of Pilates  exercises similar to the exercise group and will consume 50,000 IU of vitamin D capsules once a week in a single blind manner.</i_keyword>
      <i_keyword>Control group: There is no intervention in the control group and they are given placebo in a single blind manner.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Tumor necrosis factor-α. Timepoint: Before and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>25- hydroxy vitamin D. Timepoint: Before and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>Interleukin-10. Timepoint: Before and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>Thyroid Stimulating Hormone. Timepoint: Before and after interventions. Method of measurement: immunochemiluminescence assay.</prim_outcome>
      <prim_outcome>C-Reactive Protein. Timepoint: Before and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>Insulin. Timepoint: Before and after interventions. Method of measurement: Using the ELISA method.</prim_outcome>
      <prim_outcome>Insulin resistance. Timepoint: Before and after interventions. Method of measurement: Using the homeostasis model(HOMA-IR).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Glucose. Timepoint: Prior and after interventions. Method of measurement: Glucose oxidase assay.</sec_outcome>
      <sec_outcome>Urea. Timepoint: Prior and after interventions. Method of measurement: Urease method.</sec_outcome>
      <sec_outcome>Uric acid. Timepoint: Prior and after interventions. Method of measurement: Automatic colorimetric method.</sec_outcome>
      <sec_outcome>Creatinine. Timepoint: Prior and after interventions. Method of measurement: Jaffe methods.</sec_outcome>
      <sec_outcome>Triglyceride. Timepoint: Prior and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Low-density lipoprotein cholesterol (LDL-C). Timepoint: Prior and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>High-density lipoprotein cholesterol (HDL-C). Timepoint: Prior and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Total cholesterol. Timepoint: Prior and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Aspartate aminotransferase. Timepoint: Prior and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Alkaline phosphatase. Timepoint: Prior and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Alanine aminotransferase. Timepoint: Prior and after interventions. Method of measurement: Enzymatic method.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University Qaemshahr Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-14</approval_date>
        <contact_name>Ethics Committee of Babol branch, Islamic Azad University</contact_name>
        <contact_address>Department of physical education, Qaemshahr branch, Islamic Azad University, Qaemshahr, Iran Qaemshahr Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
